GlobalData on MSN4d
Senseonics and Ascensia announce FDA approval for one-year CGM system
Eversense 365 is said to be the world's first one-year CGM system, offering a new long-term solution for diabetes management.
FierceBiotech5d
FDA clears Senseonics' 365-day Eversense CGM implant
After collecting FDA green lights for 90- and 180-day versions, the agency has cleared the latest generation of the Eversense ...
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...
drugdeliverybusiness5d
Senseonics wins FDA nod for 365-day implantable CGM
Senseonics (NYSE:SENS) announced today that it received FDA clearance for its next-generation Eversense 365 CGM system.
Monthly Prescribing Reference5d
Long-Term CGM System Eversense 365 Gets FDA Clearance
Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management ...
FDA Approves Glucose Monitor That Can Be Worn for a Year
Senseonics, a medtech manufacturer developing long-term, implantable continuous glucose monitoring (CGM) systems, and ...
Becker's Hospital Review5d
Glucose monitor receives FDA clearance
The FDA has cleared Senseonics and Ascensia Diabetes Care's Eversense 365 Glucose Monitoring System. This system is designed for Type 1 and Type 2 diabetics 18 and older and will be the first ...
Business Insider5d
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use ...
Renal & Urology News3d
Long-Term CGM System Eversense 365 Gets FDA Clearance
Credit: Ascensia Diabetes Care. Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management. The FDA has designated the Eversense ...
Business Wire5d
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM
With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGM’s for minimal life disruption GERMANTOWN, Md. & PARSIPPANY, N.J.--(BUSINESS WIRE ...